BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 21, 2025
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for June 3, 2020

June 3, 2020
Med-tech firms raising money in public or private financings, including: Base Genomics, Inspiremd, Orasure Technologies.
Read More

Prilenia raises $62.5M to fund new trials in HD, ALS

June 3, 2020
By Michael Fitzhugh
Prilenia Therapeutics BV, a private company developing an experimental therapy for Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS), has raised $62.5 million in a series A financing round to support new trials in the indications, both of which are expected to yield top-line data by the end of 2022, CEO Michael Hayden told BioWorld.
Read More

Financings for June 3, 2020

June 3, 2020
Biopharmas raising money in public or private financings, including: Allena, Apeiron, Arca, Evofem, Innocan, Intellia, Iovance, Iterum, Hyloris, Isofol, Kaleido, Marinus, Mersana, Ourcrowd, Outlook, Pliant, Re-Vana, Shorla, Tae.
Read More

Financings for June 2, 2020

June 2, 2020
Biopharmas in Asia-Pacific raising money in public or private financings, including: Genetic Technologies, Outlook, Pneumagen.
Read More

PMI receives $7.44M to fund project to cut down on repeat cancer surgeries

June 2, 2020
By David Godkin
TORONTO – Seven years after setting up shop in downtown Toronto, high resolution, surgical imaging med-tech company Perimeter Medical Imaging Inc. (PMI) is still wrestling with a statistical heartbreaker: 1 in 4 patients told to return for a second surgery to remove cancerous breast tissue after the first surgery failed to get it all. Now PMI has said it can cut that number down dramatically thanks to a $7.44 million investment from the Austin, Texas-based Cancer Prevention and Research Institute of Texas (CPRIT) to identify wayward breast cancer cells using artificial intelligence technology.
Read More
Image from pilot animal study

Launchpad Medical nabs $1.8M grant for pivotal animal study of dental bone graft solution

June 2, 2020
By Meg Bryant
Lowell, Mass.-based startup Launchpad Medical LLC has picked up an additional $1.8 million grant from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center to advance the development of its bone graft solution. The company plans to use the funds to conduct a pivotal animal study of the injectable biomaterial, which will pave the way for a U.S. FDA-approved clinical trial.
Read More

Financings for June 2, 2020

June 2, 2020
Med-tech firms raising money in public or private financings, including: Bigfoot Biomedical, Know Labs, Labminds, Orasure Technologies, Re-Vana Therapeutics, Tae Life Sciences.
Read More

Financings for June 2, 2020

June 2, 2020
Biopharmas raising money in public or private financings, including: Adaptimmune, Allogene, Applied Molecular Transport, Argenx, Biocryst, Bionomics, Calliditas, Circassia, G1 Therapeutics, Humanigen, Pliant, Sareum.
Read More

Financings for June 1, 2020

June 1, 2020
Med-tech firms raising money in public or private financings, including: Livongo Health, Mitesco, Si-Bone.
Read More

Financings for June 1, 2020

June 1, 2020
Biopharmas raising money in public or private financings, including: Adaptimmune, Allogene, Baudax Bio, Biolinerx, Calliditas, Cleveland Biolabs, Nabriva.
Read More
Previous 1 2 … 560 561 562 563 564 565 566 567 568 … 639 640 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing